The Eiffel Tower is illuminated during the traditional Bastille Day fireworks display in Paris, July 14, 2013. (Photo by Fred Dufour/AFP Photo)

A candle burns during a vigil in Aotea Square to remember victims of the Paris attacks on November 14, 2015 in Auckland, New Zealand. According to reports, over 150 people were killed in a series of bombings and shootings across Paris, including at a soccer game at the Stade de France and a concert at the Bataclan theater. (Photo by Hannah Peters/Getty Images)

Commuters hang off a local passenger train in the morning in Colombo, Sri Lanka September 8, 2016. (Photo by Dinuka Liyanawatte/Reuters)

A man carries a blood stained stretcher in a site hit by what activists said were airstrikes carried out by the Russian air force in the town of Douma, eastern Ghouta in Damascus, Syria January 10, 2016. (Photo by Bassam Khabieh/Reuters)

A visitor poses for a picture during Sao Paulo Fashion Week in Sao Paulo, Brazil, March 16, 2017. (Photo by Nacho Doce/Reuters)

Brown-throated sloth called “43”, rescued by Juan Carlos Rodriguez and his wife Haydee in a residential area, waits in the kennel getting prepared for being released, at the couple's shelter for sloths, in San Antonio, Venezuela on July 30, 2021. (Photo by Leonardo Fernandez Viloria/Reuters)

People drink in the street in the Soho area of London, on April 12, 2021 as coronavirus restrictions are eased across the country in step two of the government's roadmap out of England's third national lockdown. Britons on Monday toasted a significant easing of coronavirus restrictions, with early morning pints – and much-needed haircuts – as the country took a tentative step towards the resumption of normal life. Businesses including non-essential retail, gyms, salons and outdoor hospitality were all able to open for the first time in months in the second step of the government's roadmap out of lockdown. (Photo by Tolga Akmen/AFP Photo)

A woman reacts as she receives a dose of the COVISHIELD vaccine against the coronavirus disease (COVID-19), manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, December 27, 2021. (Photo by Amit Dave/Reuters)